The Latest Cardiac and Vascular News
BRAINTREE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. will present the SherpaPak™ Organ Transport product line at Booth 14 during the 38th Annual Meeting of the International Society for Heart and Lung Transplantation (ISHLT) (Nice, France, 11-14 April 2018). The SherpaPak™ Organ Transport product line1,2 combines innovative cooling technology with safe, consistent methods for cold […]
DUBLIN–(BUSINESS WIRE)–The “Transradial Access Market by Product (Catheters, Guidewires, Sheath and Sheath Introducers), Application (Administration of Medicine and Administration of fluids), End User (Hospitals, Clinics & Ambulatory Centres) – Global Forecast 2022” report has been added to ResearchAndMarkets.com’s offering. The Global Transradial Access Devices Market is Expected to Grow at a CAGR of 7.5% […]
FLAGSTAFF, Ariz., April 3, 2018 /PRNewswire/ — Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen ovale (PFO) can prevent recurrent ischemic strokes, W. L. Gore & Associates, Inc. (Gore) has received approval from the U.S. Food and Drug Administration (FDA) for an expanded indication for its GORE® CARDIOFORM Septal Occluder. The device, already […]
DANVERS, Mass., April 02, 2018 (GLOBE NEWSWIRE) — Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today that it has received U.S. Food and Drug Administration (FDA) Pre-Market Approval (PMA) for its Impella CP®heart pump with SmartAssistTM, utilizing an optical sensor. At the forefront […]
CHICAGO, March 29, 2018 /PRNewswire/ — A Northwestern Memorial Hospital cardiac surgeon helped pioneer the use of an U.S. Food and Drug Administration (FDA) approved aortic valve ring as part of a triple valve repair, the first of its kind in the United States. S. Chris Malaisrie, MD, has performed two successful surgeries using the […]
VANCOUVER, BRITISH COLUMBIA — (Marketwired) — Mar 29, 2018 — Novoheart (“Novoheart” or the “Company”) (TSX VENTURE: NVH)(FRANKFURT: 3NH) is pleased to announce that it has filed a patent application on the use of its proprietary MyHeart™ Platform of human bioengineered heart tissues to create disease models for neurological diseases in which […]
WALTHAM, Mass.–(BUSINESS WIRE)– Corvidia Therapeutics Inc., a leading clinical stage biotechnology company, today announced the appointment of Marc de Garidel as Chief Executive Officer. Mr. de Garidel succeeds Corvidia’s Michael Davidson, M.D., who will remain on the company’s executive team as Chief Scientific Officer. “As we transition from a clinical stage […]
LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, has received CE Mark approval for its Bicarbon® aortic valves for use with low-dose anticoagulant therapy. The expanded CE labeling means that a lower international normalized ratio (INR), the standardized index used to measure blood coagulability, can be […]
LONDON, March 28, 2018 /PRNewswire/ — Download the full report: https://www.reportbuyer.com/product/5360520 The global cardiac resynchronization therapy (CRT) market is expected to reach USD 9.2 billion by 2025, according to a new report by Grand View Research, Inc. Increasing prevalence of cardiac disorders and rising incidences of heart failure are expected to boost the CRT market […]
DUBLIN–(BUSINESS WIRE)– The “Global Electrocardiograph (ECG) Market Analysis (2017-2023)” report has been added to ResearchAndMarkets.com’s offering. Electrocardiograph (ECG) Market was valued at $5 billion in 2016, and is estimated to reach $7 billion by 2023, growing at a CAGR of 5.8% during the forecast period. Technological advancements of ECG devices such as their portability, […]
